Correction: Exploiting PRMT5 as a Target for Combination Therapy in Mantle Cell Lymphoma Characterized by Frequent ATM and TP53 Mutations

Authors

• Yuxuan Che
• Yang Liu
• Yixin Yao
• Holly A Hill
• Yijing Li
• Qingsong Cai
• Fangfang Yan
• Preetesh Jain
• Wei Wang
• Lixin Rui
• Michael Wang

Language

English

Publication Date

4-8-2026

Journal

Blood Cancer Journal

DOI

10.1038/s41408-026-01472-4

PMID

41951585

PMCID

PMC13062123

PubMedCentral® Posted Date

4-8-2026

PubMedCentral® Full Text Version

Post-print

Comments

This corrects the article "Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations" in volume 13, 27.

Published Open-Access

yes

Recommended Citation

Che, Yuxuan; Liu, Yang; Yao, Yixin; et al., "Correction: Exploiting PRMT5 as a Target for Combination Therapy in Mantle Cell Lymphoma Characterized by Frequent ATM and TP53 Mutations" (2026). Faculty, Staff and Student Publications. 3487.
https://digitalcommons.library.tmc.edu/uthmed_docs/3487